42
Participants
Start Date
June 9, 2016
Primary Completion Date
September 24, 2018
Study Completion Date
September 2, 2019
Afatinib
Hospital Universitari de Girona Doctor Josep Trueta, Girona
Hospital Universitario Lucus Augusti, Lugo
Hospital Ramón y Cajal, Madrid
Hospital Clínico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital La Paz, Madrid
CIO Clara Campal, Madrid
INS Cancérologie du Gard, Nîmes
INS Universitaire du Cancer, Toulouse
INS Bergonié, Bordeaux
Hospital Virgen Macarena, Seville
Hospital Virgen del Rocío, Seville
Instituto Valenciano de Oncología, Valencia
Ospedale San Donato di Arezzo, Arezzo
CTR Leon Berard, Lyon
HOP Saint-Louis, Paris
HOP Cochin, Paris
HOP Européen G. Pompidou, Paris
HOP Foch, Suresnes
INS Gustave Roussy, Villejuif
A.O. San Camillo Forlanini, Roma
Hospital Germans Trias i Pujol, Badalona
Hospital del Mar, Barcelona
Hospital Santa Creu i Sant Pau, Barcelona
Hospital Clínic de Barcelona, Barcelona
Hospital Vall d'Hebron, Barcelona
Hospital Universitario de Elche, Elche
Hospital Duran i Reynals, L'Hospitalet de Llobregat
Hospital Son Espases, Palma de Mallorca
CS Parc Taulí, Sabadell
Lead Sponsor
Boehringer Ingelheim
INDUSTRY